- Armata Pharmaceuticals Announces Completion of Enrollment of Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection
- Armata Pharmaceuticals Announces Presentation at Viruses of Microbes 2024
- Armata Pharmaceuticals Announces First Quarter 2024 Results and Provides Corporate Update
Key statistics
As of last trade, Armata Pharmaceuticals Inc (ARMP:ASQ) traded at 2.97, 141.46% above the 52 week low of 1.23 set on Jul 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.00 |
---|---|
High | 3.01 |
Low | 2.92 |
Bid | 2.90 |
Offer | 2.97 |
Previous close | 3.00 |
Average volume | 12.60k |
---|---|
Shares outstanding | 36.15m |
Free float | 10.74m |
P/E (TTM) | -- |
Market cap | 108.46m USD |
EPS (TTM) | -2.20 USD |
Data delayed at least 15 minutes, as of Jul 24 2024 18:27 BST.
More ▼